OAM
JANX icon

Oxford Asset Management’s Janux Therapeutics JANX Stock Holding History

Oxford Asset Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Buy
12,844
+1,485
+13% +$21.5K 0.1% 317
2026
Q1 		$158K Sell
11,359
-11,452
-50% -$157K 0.06% 397
2025
Q4 		$315K Buy
22,811
+8,605
+61% +$202K 0.11% 286
2025
Q3 		$347K Buy
+14,206
New +$346K 0.11% 316

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Oxford Asset Management's JANX Position: Q2 2026 in Review

Oxford Asset Management increased its Janux Therapeutics (JANX) stake by 13% in Q2 2026, buying an estimated $21.5K and bringing the position to 12,844 shares worth $197K. The position accounts for 0.1% of the portfolio, ranked #317.

Oxford Asset Management first reported a position in JANX in Q3 2025 and has held it in 4 quarters since. The position peaked at $347K in Q3 2025. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Oxford Asset Management held 12,844 shares of Janux Therapeutics worth $197K as of Q2 2026.
  • Oxford Asset Management bought 1,485 Janux Therapeutics shares in Q2 2026, an estimated $21.5K.
  • Janux Therapeutics made up 0.1% of Oxford Asset Management's portfolio in Q2 2026, its #317 holding.
  • Oxford Asset Management first reported a position in Janux Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Oxford Asset Management's Janux Therapeutics position peaked at $347K in Q3 2025.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.